Your browser doesn't support javascript.
loading
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas.
Wu, Jing; Yuan, Ying; Long Priel, Debra A; Fink, Danielle; Peer, Cody J; Sissung, Tristan M; Su, Yu-Ting; Pang, Ying; Yu, Guangyang; Butler, Madison K; Mendoza, Tito R; Vera, Elizabeth; Ahmad, Salman; Bryla, Christine; Lindsley, Matthew; Grajkowska, Ewa; Mentges, Kelly; Boris, Lisa; Antony, Ramya; Garren, Nancy; Siegel, Christine; Lollo, Nicole; Cordova, Christine; Aboud, Orwa; Theeler, Brett J; Burton, Eric M; Penas-Prado, Marta; Leeper, Heather; Gonzales, Javier; Armstrong, Terri S; Calvo, Katherine R; Figg, William D; Kuhns, Douglas B; Gallin, John I; Gilbert, Mark R.
Afiliación
  • Wu J; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. jing.wu3@nih.gov.
  • Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Long Priel DA; Neutrophil Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Fink D; Neutrophil Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Peer CJ; Clinical Pharmacology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Sissung TM; Clinical Pharmacology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Su YT; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Pang Y; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Yu G; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Butler MK; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vera E; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Ahmad S; The Clinical Center, NIH, Bethesda, Maryland.
  • Bryla C; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Lindsley M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Grajkowska E; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Mentges K; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Boris L; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Antony R; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Garren N; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Siegel C; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Lollo N; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Cordova C; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Aboud O; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Theeler BJ; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Burton EM; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Leeper H; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Gonzales J; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Calvo KR; The Clinical Center, NIH, Bethesda, Maryland.
  • Figg WD; Clinical Pharmacology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Kuhns DB; Neutrophil Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Gallin JI; The Clinical Center, NIH, Bethesda, Maryland.
  • Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Clin Cancer Res ; 27(12): 3298-3306, 2021 06 15.
Article en En | MEDLINE | ID: mdl-33785481
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Astrocitoma / Neoplasias Encefálicas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Astrocitoma / Neoplasias Encefálicas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article